Breast lifts and reductions are booming while traditional augmentation loses its dominance, driven by changing regional trends. Manhasset, New York, United States, June 30, 2025 — Breast lifts and reductions are booming while traditional augmentation… Read More »Plastic Surgery Data Reveals a Cultural Shift in Cosmetic Breast Procedures
HONG KONG, June 30, 2025 /PRNewswire/ — GIBO Holdings Ltd. (NASDAQ: GIBO), a leading innovator in intelligent content infrastructure, today announced the successful testing of its AI-driven engine, GIBO Click, on uDrama, a rising… Read More »GIBO Click Powers Intelligent Monetization Trials on uDrama, Enhancing Multicurrency Transactions and Viewer Insights
ARLINGTON, Va., June 30, 2025 /PRNewswire/ — Muqing Li has been assigned as the Lead Performance Engineer for the largest solar-plus-storage project in the United States, commissioned by AES Corporation, a Fortune 500 global energy… Read More »Muqing Li: Pioneering Robotic Vision for Autonomous Solar Deployment in the Age of AI and Renewable Energy
NEW YORK, June 30, 2025 /PRNewswire/ — OneOdio, a global leader in audio innovation, proudly announces the launch of the Focus A6, its most premium and design-forward headphones to date. With powerful hybrid active… Read More »OneOdio Unveils Focus A6: Latest ANC Headphones with CNC-Milled Aviation-grade Aluminum Alloy CD Patterns
Partnership aims to redefine new fan experiences across global music markets Beyond Music to expand its presence in the Japanese market through UTAGE3.0’s network Companies to seek a variety of business opportunities like developing… Read More »Beyond Music Signs Strategic MOU with Japan-Based Startup UTAGE3.0
TOKYO, June 30, 2025 /PRNewswire/ — Alpha Fusion, Inc. (“Alpha Fusion”) and Curadh MTR Inc. (“Curadh”) announced plans to enter a strategic partnership, including a Joint Venture to broadly advance the global development of Astatine-211… Read More »Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals